Other OTC - Delayed Quote • USD
Mera Pharmaceuticals, Inc. (MRPI)
At close: April 5 at 11:38 AM EDT
Breakdown
TTM
Total Revenue
302.6240
Cost of Revenue
16.2600
Gross Profit
286.3640
Operating Expense
487.4180
Operating Income
-201.0540
Net Non Operating Interest Income Expense
-5.8110
Other Income Expense
4.9980
Pretax Income
-201.8670
Tax Provision
-14.1870
Net Income Common Stockholders
-220.6180
Diluted NI Available to Com Stockholders
-220.6180
Basic Average Shares
547,769.9150
Diluted Average Shares
547,769.9150
Total Operating Income as Reported
-201.0540
Total Expenses
503.6780
Net Income from Continuing & Discontinued Operation
-187.6800
Normalized Income
-192.3267
Interest Expense
5.8110
Net Interest Income
-5.8110
EBIT
-196.0560
EBITDA
-187.7560
Reconciled Cost of Revenue
16.2600
Reconciled Depreciation
8.3000
Net Income from Continuing Operation Net Minority Interest
-187.6800
Total Unusual Items Excluding Goodwill
4.9980
Total Unusual Items
4.9980
Normalized EBITDA
-192.7540
Tax Rate for Calcs
0.0001
Tax Effect of Unusual Items
0.3513
-
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
ANR.AX Anatara Lifesciences Ltd
0.0480
+4.35%
CLCS Cell Source, Inc.
0.0002
0.00%
RSPI RespireRx Pharmaceuticals Inc.
0.0009
+2.35%
PKTX ProtoKinetix, Incorporated
0.0155
-18.42%
EDSA Edesa Biotech, Inc.
4.4684
+2.25%
ATHE Alterity Therapeutics Limited
2.2600
-4.64%
EVFM Evofem Biosciences, Inc.
0.0142
-4.70%
PROK ProKidney Corp.
2.7100
0.00%
VAXX Vaxxinity, Inc.
0.1214
-8.45%
INCY Incyte Corporation
51.18
-1.08%